Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Paulzen

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Schizophrenia Research|December 21, 2016
Effect of smoking on risperidone pharmacokinetics - A multifactorial approach to better predict the influence on drug metabolismGeorgios Schoretsanitis, Ekkehard Haen, Benedikt Stegmann, et al.
Patient Preference and Adherence|November 19, 2025
Treatment Goals in Schizophrenia: Subgroup Analysis of a Survey in Matched Physician-Patient PairsGerhard Gründer, Philipp Bauknecht, Stefanie Schell, et al.
The Journal of Clinical Psychiatry|September 5, 2014
Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluidMichael Paulzen, Sarah Groppe, Simone C Tauber, et al.
Journal of Affective Disorders|October 6, 2015
Duloxetine enters the brain - But why is it not found in the cerebrospinal fluidMichael Paulzen, Gerhard Gründer, Tanja Veselinovic, et al.
Schizophrenia Research|October 3, 2017
Pregnancy exposure to quetiapine - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomesMichael Paulzen, Tamme W Goecke, Maxim Kuzin, et al.
Clinical Pharmacokinetics|October 1, 2020
Elevated Clozapine Concentrations in Clozapine-Treated Patients with HypersalivationGeorgios Schoretsanitis, Maxim Kuzin, John M Kane, et al.
Basic & Clinical Pharmacology & Toxicology|April 17, 2023
Discovering interactions in augmentation strategies: Impact of duloxetine on the metabolism of aripiprazoleTeresa Margraff, Georgios Schoretsanitis, Irene Neuner, et al.
Journal of Affective Disorders|February 15, 2020
Pregnancy exposure to venlafaxine-Therapeutic drug monitoring in maternal blood, amniotic fluid and umbilical cord blood and obstetrical outcomesMichael Paulzen, Georgios Schoretsanitis, Gerhard Gründer, et al.
CNS Drugs|November 29, 2019
Clinically Significant Drug-Drug Interactions with Agents for Attention-Deficit/Hyperactivity DisorderGeorgios Schoretsanitis, Jose de Leon, Chin B Eap, et al.
Psychiatry Research|March 27, 2025
Unraveling antipsychotic induced weight gain in schizophrenia - A proof-of-concept study exploring the impact of the cumulative historical occupancy of different receptors by antipsychoticsFederico Pacheco Sudar, Samar Samy Zekerallah, Michael Paulzen, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Schizophrenia Research|December 21, 2016
Effect of smoking on risperidone pharmacokinetics - A multifactorial approach to better predict the influence on drug metabolismGeorgios Schoretsanitis, Ekkehard Haen, Benedikt Stegmann, et al.
Patient Preference and Adherence|November 19, 2025
Treatment Goals in Schizophrenia: Subgroup Analysis of a Survey in Matched Physician-Patient PairsGerhard Gründer, Philipp Bauknecht, Stefanie Schell, et al.
The Journal of Clinical Psychiatry|September 5, 2014
Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluidMichael Paulzen, Sarah Groppe, Simone C Tauber, et al.
Journal of Affective Disorders|October 6, 2015
Duloxetine enters the brain - But why is it not found in the cerebrospinal fluidMichael Paulzen, Gerhard Gründer, Tanja Veselinovic, et al.
Schizophrenia Research|October 3, 2017
Pregnancy exposure to quetiapine - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomesMichael Paulzen, Tamme W Goecke, Maxim Kuzin, et al.
Clinical Pharmacokinetics|October 1, 2020
Elevated Clozapine Concentrations in Clozapine-Treated Patients with HypersalivationGeorgios Schoretsanitis, Maxim Kuzin, John M Kane, et al.
Basic & Clinical Pharmacology & Toxicology|April 17, 2023
Discovering interactions in augmentation strategies: Impact of duloxetine on the metabolism of aripiprazoleTeresa Margraff, Georgios Schoretsanitis, Irene Neuner, et al.
Journal of Affective Disorders|February 15, 2020
Pregnancy exposure to venlafaxine-Therapeutic drug monitoring in maternal blood, amniotic fluid and umbilical cord blood and obstetrical outcomesMichael Paulzen, Georgios Schoretsanitis, Gerhard Gründer, et al.
CNS Drugs|November 29, 2019
Clinically Significant Drug-Drug Interactions with Agents for Attention-Deficit/Hyperactivity DisorderGeorgios Schoretsanitis, Jose de Leon, Chin B Eap, et al.
Psychiatry Research|March 27, 2025
Unraveling antipsychotic induced weight gain in schizophrenia - A proof-of-concept study exploring the impact of the cumulative historical occupancy of different receptors by antipsychoticsFederico Pacheco Sudar, Samar Samy Zekerallah, Michael Paulzen, et al.
Pageof 10